Mirum Pharmaceuticals, Inc. MIRM Business Segments — Amortization expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s business segments — amortization expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s business segments — amortization expense?
- Mirum Pharmaceuticals, Inc. (MIRM) reported business segments — amortization expense of $6.69M in Q1 2026.
- What does business segments — amortization expense mean?
- Represents the systematic allocation of the cost of intangible assets, such as patents or acquired licenses, over their useful lives. This non-cash expense reflects the consumption of the economic value of the company's intellectual property portfolio.